CECOG Academy
R

SABCS Updates on TNBC: Chemotherapy, Biomarkers, PARPi, AKTi, CDK4/6i, Sacituzumab Govitecan, Neoadjuvant Atezolizumab & Pembrolizumab

By CECOG Academy FEATURING Rupert Bartsch
By CECOG Academy FEATURING Rupert Bartsch
175 views
March 29, 2021
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
17:20
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino
14:16
Dana-Farber Cancer Institute

Year in Review: Breast Cancer

Feat. P. Tarantino
04:28
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant …

Feat. S. Tolaney
07:50
Oncology Data Advisor

ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, &a…

Feat. K. Kalinsky
22:34
Dana-Farber Cancer Institute

What's New in Breast Cancer?

Feat. S. Tolaney
30:46
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"

Feat. S. Tolaney, H. Rugo
24:36
ESMO 2022 Conference Coverage

ESMO 2022 Breast Cancer Panel Discussion: Practice-Changing Updates

Feat. H. Rugo, J. O'Shaughnessy
12:21
Insights from 2023 SABCS

SABCS 2023 Insights: "How to Treat TNBC"

Feat. P. Sharma
20:42
Total Health

2022 Updates in TNBC

Feat. I. Schlam
03:37
Insights from 2023 SABCS

SABCS 2023 Summary: "Is There a Role for Purely Adjuvant IO in …

Feat. S. Tolaney, H. Rugo
07:49
UChicago Medicine

Antibody Drug Conjugates: Overview and Background of a Revolution in…

Feat. H. Rugo
11:10
Dana-Farber Cancer Institute

Antibody Drug Conjugates in Breast Cancer

Feat. S. Tolaney
35:14
OncoAlert

Advanced TNBC Updates

Feat. H. Rugo
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
09:51
Cleveland Clinic Taussig Cancer Institute

Mitigation of Cytopenia and Diarrhea Associated With Sacituzumab Gov…

Feat. E. Roesch
16:08
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Tailoring Post-Neoadjuvant Therapy in TNB…

Feat. H. Han
17:57
UChicago Medicine

Neoadjuvant & Adjuvant Therapy for High-Risk, Early Stage TNBC

Feat. R. Nanda
08:23
Total Health

52 y/o With T2N0 Grade III TNBC: Case Presentation and Panel Discuss…

Feat. P. Sharma, M. Telli, K. Kalinsky
07:49
ESMO Breast Cancer 2023 Congress Coverage

ESMO Breast Cancer 2023 KEYNOTE-355 Trial: Outcomes in TNBC Patients…

Feat. H. Rugo
14:15
Insights from 2023 SABCS

SABCS 2023 Insights: "KEYLYNK-009 Study - Pembro + Olaparib vs.…

Feat. H. Rugo